ArticleMolecular pharmaceutics2023

Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate.

Douglas S MacPherson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.